Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares Core MSCI EAFE ETF (IEFA) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance

iShares Core MSCI EAFE ETFTrade
Roivant Sciences Ltd. Common SharesTrade

Price performance (Past 24H)

Key statistics

iShares Core MSCI EAFE ETF vs Roivant Sciences Ltd. Common Shares — how do they compare? iShares Core MSCI EAFE ETF trades at $96.18 (market cap $189.19B), while Roivant Sciences Ltd. Common Shares trades at $34.88 (market cap $24.72B). The key difference: iShares Core MSCI EAFE ETF is far larger — about 7.7× Roivant Sciences Ltd. Common Shares's market cap, and iShares Core MSCI EAFE ETF is more actively traded (8,441,787 versus 6,279,442). Which is the better fit depends on your goals — on Pluang, investors hold iShares Core MSCI EAFE ETF for 41 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.

IEFAROIV
Market Cap
$189.19B$24.72B
Volume
8,441,7876,279,442
Sector
Broad Market / FactorHealth
52-Week High
$101.41$41.81
52-Week Low
$85.06$16.04
Typical Hold Time
41 Days0 Days
Enterprise Value
—$20.99B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares Core MSCI EAFE ETF

IEFA trades at $96.18, down 0.02% on the day, with a bearish technical outlook indicated by moving averages and oscillators. The ETF, managed by BlackRock, holds $196 billion in assets and focuses on developed markets outside North America. Recent news highlights comparisons with competing international ETFs, noting its higher dividend yield and lower expense ratio relative to some peers, though performance has lagged behind certain total-world and emerging market funds over the past year.

The outlook for IEFA is clouded by technical weakness and competitive pressures, though its scale and cost efficiency offer stability. Key risks include concentration in developed markets, which may underperform during global growth shifts, and the impact of geopolitical tensions on international equities. Analyst sentiment is mixed, with the fund's defensive characteristics balancing against limited near-term catalysts.

Roivant Sciences Ltd. Common Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IEFA
100% Buy0% Sell
Avg holding period · 41 Days
ROIV
100% Buy0% Sell
Avg holding period · 0 Days

About iShares Core MSCI EAFE ETF

IEFA tracks the MSCI EAFE Investable Market Index, offering broad exposure to large, mid, and small-cap stocks in developed markets across Europe, Australasia, and the Far East. It serves as a low-cost core holding for international diversification, excluding the U.S. and Canada.

Read more on IEFA →

About Roivant Sciences Ltd. Common Shares

Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.

Read more on ROIV →